Proprotein convertase subtilisin/kexin type 9 levels and the risk of cardiovascular events in statin-treated patients with cardiovascular disease

Authors: M Gohbara, K Hibi, K Uemura, N Iwahashi, K Okada, Y Fukumoto, Y Ozaki, K Miyauchi, Y Nakagawa, H Ogawa, H Daida, H Shimokawa, T Kimura, K Kimura, R Nagai

Published: 2024-10-28

DOI: 10.1093/eurheartj/ehae666.2811

Source: Full article

Proprotein convertase subtilisin/kexin type 9 levels and the risk of cardiovascular events in statin-treated patients with cardiovascular disease

Abstract